BiotechTube
Jabez Biosciences

Jabez Biosciences

San Diego, United States· Est.
jabezbio.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Jabez Biosciences is a private, pre-revenue biotech advancing a novel '3-S' framework for oncology drug development, prioritizing patient-friendly, manufacturable, and combination-ready therapies. The company's lead asset, JBZ-001, is in Phase 1, demonstrating its model's initial validation. Led by a seasoned team with extensive drug development experience, Jabez is actively raising capital through a Reg A+ offering to fund clinical milestones and pipeline expansion.

Oncology

Technology Platform

The '3-S' development and selection framework: Seamless (patient-friendly, oral), Scalable (low-cost manufacturing), Synergistic (rational combination with standard-of-care).

Opportunities

The 3-S model targets major unmet needs in oncology: improving efficacy without adding toxicity or cost.
Success with JBZ-001 could validate the platform, enabling rapid portfolio expansion through in-licensing and creating significant partnership or acquisition appeal for larger pharma companies seeking synergistic, late-stage assets.

Risk Factors

The company faces high clinical risk with its single lead asset; failure would invalidate its core platform.
It is entirely dependent on successful fundraising via its Reg A+ offering to continue operations and clinical trials.
The competitive landscape for DHODH inhibitors and in-licensing attractive oncology assets is intense.

Competitive Landscape

Jabez competes with other developers of oral, small molecule oncology drugs and DHODH inhibitors specifically. Its key differentiator is the integrated 3-S commercial and development filter, which aims to de-risk programs for patient compliance, manufacturing, and clinical integration from the start, a holistic approach less commonly emphasized by pure discovery-platform companies.

More companies in Small Molecule Drugs →More companies in United States →